Clinical trials
Active, not recruiting Phase 1/2 Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 2 |
| Seattle Children's Hospital | 2 |
| Allogene Therapeutics | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Bellicum Pharmaceuticals | 1 |
| Celgene | 1 |
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Kura Oncology, Inc. | 1 |
| Ossium Health, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 14 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma | 5 |
| Recurrence | 4 |
| Hematologic Neoplasms | 3 |
| Leukemia, B-Cell | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Immune System Diseases | 2 |
| Leukemia, Biphenotypic, Acute | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.